Area A
Pulmonary circulation, aberrant remodeling in PH and design of reverse remodeling treatment concepts The third funding period projects from 1 July, 2024 untill 30 June, 2028.
https://www.uni-giessen.de/de/fbz/fb11/forschung/projekte/sfb/SFB1213/projects/areaa
https://www.uni-giessen.de/@@site-logo/logo.png
Inhaltspezifische Aktionen
Area A
Pulmonary circulation, aberrant remodeling in PH and design of reverse remodeling treatment concepts The third funding period projects from 1 July, 2024 untill 30 June, 2028.
FOXO transcription factors in PH: critical integrators of multiple immune signaling pathways driving pulmonary vascular and right ventricular remodeling
Pathways for BMP9/10 responsiveness in smooth muscle cells, critical for pulmonary hypertension and right heart failure
Origin and fate of vascular myofibroblasts and smooth muscle cells during pulmonary vascular remodeling and reverse remodeling
Regulatory network of histone modifications in human pulmonary arterial hypertension
Sensing and signaling events underlying development and recovery of hypoxia-induced pulmonary hypertension
iNOS- and NoxO1-based redox signaling in COPD-associated PH – pathomechanisms and therapeutic exploitation
Kinase signaling driving “pseudo-malignant” lung vascular remodeling – therapeutic exploitation
Inflammatory lung microenvironment in lung cancer-associated pulmonary hypertension
Disturbed proteoglycan homeostasis drives pulmonary hypertension in lung fibrosis
